Skip to main navigation Skip to search Skip to main content

RNA-binding proteins hnRNPM and ELAVL1 promote type-I interferon induction downstream of the nucleic acid sensors cGAS and RIG-I

  • A Kirchhoff
  • , AM Herzner
  • , C Urban
  • , A Piras
  • , R Düster
  • , J Mahlberg
  • , A Grünewald
  • , TM Schlee-Guimaraes
  • , K Ciupka
  • , P Leka
  • , RJ Bootz
  • , C Wallerath
  • , C Hunkler
  • , AK de Regt
  • , BM Kümmerer
  • , MH Christensen
  • , F Schmidt
  • , MA Lee-Kirsch
  • , C Günther
  • , H Kato
  • E Bartok, G Hartmann, M Geyer, A Pichlmair, M Schlee

Research output: Contribution to journalA1: Peer-reviewed journal articlespeer-review

Abstract

The cytosolic nucleic acid sensors RIG-I and cGAS induce type-I interferon (IFN)-mediated immune responses to RNA and DNA viruses, respectively. So far no connection between the two cytosolic pathways upstream of IKK-like kinase activation has been investigated. Here, we identify heterogeneous nuclear ribonucleoprotein M (hnRNPM) as a positive regulator of IRF3 phosphorylation and type-I IFN induction downstream of both cGAS and RIG-I. Combining interactome analysis with genome editing, we further uncover the RNA-binding protein ELAV-like protein 1 (ELAVL1; also known as human antigen R, HuR) as an hnRNPM interactor. Depletion of hnRNPM or ELAVL1 impairs type-I IFN induction by herpes simplex virus 1 or Sendai virus. In addition, we show that hnRNPM and ELAVL1 interact with TANK-binding kinase 1, IκB kinase ε, IκB kinase β, and NF-κB p65. Our confocal microscopy experiments demonstrate cytosolic and perinuclear interactions between hnRNPM, ELAVL1, and TBK1. Furthermore, pharmacological inhibition of ELAVL1 strongly reduces cytokine release from type-I interferonopathy patient fibroblasts. The RNA-binding proteins hnRNPM and ELAVL1 are the first non-redundant regulators to bridge the cGAS/STING and RIG-I/MAVS pathways. Overall, our study characterizes the hnRNPM-ELAVL1 complex as a novel system promoting antiviral defense, pointing to a potential therapeutic target to reduce auto-inflammation in patients with type-I interferonopathies.
Original languageEnglish
JournalEmbo Journal
Volume44
Issue number3
Pages (from-to)824-853
Number of pages30
ISSN0261-4189
DOIs
Publication statusPublished - Feb-2025

Keywords

  • ELAVL1
  • IRF3
  • RIG-I Signaling
  • CGAS Signaling
  • HnRNPM
  • Phosphorylation
  • DEAD Box Protein 58/metabolism
  • Signal Transduction
  • Humans
  • ELAV-Like Protein 1/metabolism
  • Interferon Regulatory Factor-3/metabolism
  • HEK293 Cells
  • Nucleotidyltransferases/metabolism
  • Protein Serine-Threonine Kinases/metabolism
  • Receptors, Immunologic
  • Interferon Type I/metabolism
  • Herpesvirus 1, Human/immunology

Fingerprint

Dive into the research topics of 'RNA-binding proteins hnRNPM and ELAVL1 promote type-I interferon induction downstream of the nucleic acid sensors cGAS and RIG-I'. Together they form a unique fingerprint.

Cite this